Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Total debt
Total debt on the balance sheet as of June 2023 : $3.09 Billion USD
According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's total debt is $3.09 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Mallinckrodt Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $3.07 B | 121.17% |
| 2021-12-31 | $1.38 B | -61.29% |
| 2020-12-31 | $3.58 B | -33.25% |
| 2019-12-31 | $5.37 B | -11.77% |
| 2018-12-31 | $6.09 B | -9.55% |
| 2017-12-31 | $6.73 B | |
| 2016-09-30 | $6.04 B | -6.95% |
| 2015-09-30 | $6.49 B | 63.53% |
| 2014-09-30 | $3.97 B | 331.91% |
| 2013-09-30 | $0.91 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | $36.63 B | 1,082.28% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
 | $18.07 B | 483.46% | 🇮🇱 Israel |
 | $19.27 B | 521.99% | 🇺🇸 USA |